-
The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams.
Please read these conditions carefully before using this site. By using this site, you signify your assent to the following terms and conditions of use without limitation or qualification. In particular, you consent to the use of all cookies on this website for the purposes described in the terms of use. If you do not agree to these terms or to the use of cookies as described below, do not use this site. AllianceBernstein may at any time revise these terms of use. You are bound by any such revisions and should therefore periodically visit this page to review the then current terms of use to which you are bound. This site is for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy any security which may be referenced herein.
This site is solely intended for use by professional/institutional investors and institutional-investment industry consultants.
Do you wish to continue?
Price/Forward Earnings (Oct 1999–Oct 2017)
As of October 31, 2017
Past performance and current analyses do not guarantee future results.
Price/earnings ratio based on estimated earnings for the next 12 months. Dashed line represents the average P/E ratio, based on estimated earnings for the next 12 months, form October 31, 1999, through October 31, 2017. EPS growth is earnngs-per-share long-term growth. PEG is price/earnings-to-growth ratio for the next 12 months. PEG percent rank versus history is based on monthly percentiles from November 1, 2007, through October 31, 2017.
US is represented by S&P 500, non-US developed by MSCIEAFE and emerging markets by MSCI Emerging Markets.
Source: FactSet, MSCI, S&P and AllianceBernstein (AB)
The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams.
Scott Krauthamer is a Senior Vice President and Global Head of Product Management & Strategy, overseeing AB's global investment products across the firm's equity, fixed income and multi-asset strategies. Prior to joining the firm, he held a variety of investment and product-management roles at Legg Mason, U.S. Trust, Bank of America and J.P. Morgan Private Bank. Krauthamer started his career as an analyst at J.P. Morgan in 1998, and his financial-services experience spans investment-management, quantitative analysis, marketing and business development. He holds a BS in finance and management information systems from the State University of New York, Albany, and is a CFA charterholder and a CAIA designee. Location: Nashville
Christopher W. Marx is Senior Vice President and Global Head of Equity Business Development. He is responsible for overseeing the firm's team of equity investment strategists and product managers, setting strategic priorities and goals for the global Equities business, developing new products, and engaging with clients to represent market views and investment strategies of the firm. Previously, Marx was a senior investment strategist and a portfolio manager of Equities, and in 2011 he cofounded the Global, International and US Strategic Core Equity portfolios with Kent Hargis. He joined the firm in 1997 as a research analyst covering a variety of industries both domestically and internationally, including chemicals, metals, retail and consumer staples. Marx became part of the portfolio-management team in 2004. Prior to joining the firm, he spent six years as a consultant for Deloitte & Touche and Boston Consulting Group. Marx holds a BA in economics from Harvard University and an MBA from the Stanford Graduate School of Business. Location: New York
With more investors looking for defensive trades, what counts as a defensive trade in today’s environment? Differences in valuation—and different interpretations of what counts as defensive—mean that not all such trades are equal.
Inigo Fraser-Jenkins | 20 March 2025Staying invested in EM stocks can help avoid sacrificing attractive return potential.
Sammy Suzuki | 20 March 2025Though geopolitics has come to the fore, insurers are addressing a wide range of other issues.
Bob Sharma, Gerry Anderson | 19 March 2025